Ipragliflozin , a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes.
about
Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 TrialThe role of empagliflozin in the management of type 2 diabetes by patient profile.Moieties in antidiabetic drugs as a target of insulin receptors in association with common neurological disorders.Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes.An update on DPP-4 inhibitors in the management of type 2 diabetes.Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2 diabetes.A concise and practical stereoselective synthesis of ipragliflozin L-proline.
P2860
Q33614337-E80F9C20-E177-466F-BF6D-1B348C4F4A45Q35592873-B6B75C2E-118D-4C19-B616-AE868B229479Q36742174-5815AB96-5FA5-4217-A865-E00A0EF48104Q37421058-F4FBD9CA-7FA4-4231-A1D3-9DC3B3661B0CQ38997456-176E7027-EDAC-461E-B759-C63A17D4CA90Q39000172-116D3E92-AF99-4C0A-97AB-CD6CA3088A96Q41070264-0F019257-6BC2-47DC-A656-4EBF73B54A83
P2860
Ipragliflozin , a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ipragliflozin , a sodium-gluco ...... treatment of type 2 diabetes.
@en
type
label
Ipragliflozin , a sodium-gluco ...... treatment of type 2 diabetes.
@en
prefLabel
Ipragliflozin , a sodium-gluco ...... treatment of type 2 diabetes.
@en
P2860
P1476
Ipragliflozin , a sodium-gluco ...... treatment of type 2 diabetes.
@en
P2093
Maka S Hedrington
Stephen N Davis
P2860
P304
P356
10.1517/17425255.2015.1009893
P407
P577
2015-02-02T00:00:00Z